Notícias

SARS-COV-2 infection has affected millions of individuals with a wide range of clinical manifestations, including central and peripheral nervous systems...

Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We...

Formulário para sugestões ficará disponível até 15 de setembro

Preapproval trials showed that messenger RNA (mRNA)–based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety...

O Graphene Brazil Tech, tem como objetivo promover novos formatos e arenas para a
produção e o compartilhamento de...

Coronavirus disease 2019 (COVID-19) pandemic is caused by the novel coronavirus that has spread rapidly around the world, leading to...

The novel coronavirus disease, caused by severe acute respiratory coronavirus 2 (SARS-CoV-2), rapidly spreading around the world, poses a major...

ABIFINA congratula novo presidente da Academia Nacional de Farmácia. Entidade
participa da cerimônia de posse da ACFB/ANF, na qual...

ABIFINA participa da 4ª reunião ordinária de 2021 do Conselho Nacional de Combate
à Pirataria (CNCP), órgão colegiado do...

Coronavirus disease 19 (COVID-19) can have a severe presentation characterized by a dysregulated immune response requiring admission to the intensive...

Academia NC, criada pelo Grupo NC, ao qual pertence a EMS, maior laboratório
farmacêutico no Brasil, desenvolveu plataforma digital...

Robust evidenced treatment strategy for Coronavirus disease 2019 (COVID-19) has not been established yet. Early, targeted, comprehensive management approach can...